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Tubulogenesis controls  
cell specification
Kesavan et al., Cell 2009; 139: 791–801; doi:10.1016/j.cell.2009.08.049
Many organs, such as the kidney, lung, pancreas, salivary gland, 
prostate, and mammary gland, are primarily made up of tubes 
that transport fluids and gases and, in the adult, contain many cell 
types. Needless to say, tubulogenesis involves multiple dynamic 
and interdependent cellular processes, including cytoskeletal 
reorganization, assembly of intercellular junctional complexes, 
cell polarization, and cell-fate determination. Rho-GTPases are 
molecular switches that control such complex processes. Cell divi-
sion control protein 42 homolog (Cdc42), one of the most studied 
Rho-GTPases, is a master regulator of cytoskeletal dynamics and 
cell polarity. Recently, Cdc42 was shown to control lumen forma-
tion in three-dimensional organotypic cultures of Madin-Darby 
canine kidney cells, but whether Cdc42 controls lumen formation 
in vivo remains unclear. Recently, Kesavan et al. used the mouse 
pancreas to address two critical and related questions in develop-
mental biology: the molecular control of mammalian tubulogen-
esis in vivo and the interplay between tube formation and cell-fate 
decisions during organogenesis. They found that the formation 
of pancreatic tubes starts with the initiation of scattered microlu-
mens throughout the epithelium. These lumens expanded not by 
sprouting, but by spreading of cell polarization. The subsequent 
fusion of lumens generated the interconnected tubular system. By 
ablating Cdc42 (Cdc42 KO) at different time points during pan-
creas development, the authors found that Cdc42 was required 
for microlumen formation and for maintenance of the polarized 
tubular phenotype. Of great interest is their finding that the failure 
to organize pancreatic epithelial progenitors into tubes caused a 
dramatic upregulation of acinar cell differentiation (Figure) at the 
expense of duct and endocrine cell differentiation. In vitro culture 
of the embryonic pancreas showed that in the absence of the mes-
enchyme, both wild-type and Cdc42 KO explants generated the 
same number of endocrine cells, indicating that Cdc42 controls 
endocrine cell differentiation in a cell-autonomous manner. This 
finding suggests that altered tissue architecture and/or microen-
vironment caused the Cdc42 KO-induced changes in cell-fate 
specification. Thus, at least in the pancreas, tubes are necessary 
for proper cell-fate specification, and Cdc42’s role in determining 
tissue architecture generates microenvironments permissive for 
specification of pancreatic progenitors.
Juan Oliver
Whole-body UVA irradiation  
lowers arterial pressure
Opländer et al., Circ Res 2009; 105: 1031–1040; doi:10.1161/
CIRCRESAHA.109.207019
The level of arterial pressure and the incidence of hypertension 
vary throughout the world, and many factors account for this 
variation. Interestingly, it has long been known that arterial pres-
sure levels increase at increasing distances from the equator, and 
in many populations, arterial pressure is higher in winter than in 
summer. Needless to say, these observations have triggered a vari-
ety of hypotheses in which vitamin D has played a prominent role. 
The recent discovery of the interaction of vitamin D with renin has 
further focused attention on the vitamin’s role in pressure regula-
tion. However, there might be an additional mechanism by which 
ambient electromagnetic radiation could affect arterial pressure. 
Furchgott et al. long ago noted that exposure to sunlight relaxed 
isolated arteries.1 This photorelaxation was wavelength-dependent, 
increasing as wavelength was reduced from the visible to the ultra-
violet (UV) range; was independent of the endothelium; and was 
potentiated by solutions containing nitrite. Nitrite is a constituent 
of sweat, assumed to be formed on the skin surface by commensu-
ral bacteria. In addition, nitric oxide (NO) production by NO syn-
thase (NOS) likely occurs in all dermal cell types. Some of the NO 
formed generates nitroso compounds, for example, S-nitrosothiols 
(RS-NOs) or mercuric chloride-nonsensitive nitroso compounds, 
or the oxidation products nitrite and nitrate. UVA penetrates deep 
enough into skin to reach the microvessels; thus photosensitive NO 
derivates such as RS-NOs or nitrite may undergo photodecompo-
sition when irradiated with UVA light, resulting in the formation 
of bioactive NO. Previous studies found that UVA exposure of 
healthy skin caused enzyme-independent generation of NO for-
mation, which reached concentrations comparable to or higher 
than those found with maximal activity of the inducible NOS. 
Opländer et al. extend these observations, investigating the effect 
Cdc42 ablation increased acinar cell differentiation. Embryonic day 15.5 wild-
type (WT) and Cdc42 KO pancreata were immunostained with antibodies 
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of whole-body UVA exposure on systemic blood circulation in 
humans. They found that UVA illumination increased the intra-
dermal level of free NO and RS-NOs  and the subfraction of dermal 
S-nitrosoalbumin. In healthy volunteers treated with a skin cream 
containing isotopically labeled 15N-nitrite, whole-body UVA irra-
diation induced significant levels of 15N-labeled RS-NOs fin the 
blood plasma. Moreover, whole-body UVA irradiation caused a 
rapid decrease in arterial pressure, which lasted up to 60 minutes 
(Figure). Thus, UVA irradiation of human skin decreases arterial 
pressure, and this effect is likely due to UV-induced release of NO 
from cutaneous photolabile NO derivates.
Juan Oliver
1J Gen Physiol 1961; 44: 499–519.
Regulation of endocytosis of the 
ROMK potassium secretory channel
Fang et al., J Clin Invest 2009; 119: 3278–3289; doi:10.1172/JCI37950
The renal outer medullary potassium (ROMK) (Kir1.1) subfamily 
of inward-rectifying potassium channels plays a critical role in 
renal potassium excretion and thus potassium balance. The chan-
nels are expressed on the apical membrane of the principal cells 
of the distal nephron, where they provide the final route for renal 
potassium secretion. The channels are known to be regulated by 
several factors critical in potassium homeostasis, such as plasma 
potassium concentration, aldosterone, and the like. ROMK chan-
nels are constitutively open, and thus changes in channel function 
are largely due to changes in the density of functional channels at 
the apical surface. It is clear that clathrin-dependent endocytosis 
plays a central role, as, for example, in states of dietary potassium 
deficiency, ROMK channels are retrieved from the apical surface 
to limit urinary potassium loss and maintain potassium balance. 
Previous work has also shown that that ROMK endocytosis is 
stimulated by the with-no-lysine (WNK) kinases. But, despite its 
importance, the molecular mechanisms responsible for ROMK 
endocytosis are not well understood. In a recent communication, 
Fang et al. report that ROMK bound directly to the clathrin adap-
tor molecule autosomal recessive hypercholesterolemia (ARH), 
and that this interaction was mediated by a novel variant of the 
canonical ‘NPXY’ endocytotic signal, YxNPxFV. They found 
that ARH recruited ROMK to clathrin-coated pits for constitu-
tive and WNK1-stimuated endocytosis. Further, ARH knock-
down decreased basal rates of ROMK endocytosis in COS-7 
cells. ARH was detected predominantly in the distal nephron, 
where it colocalized with ROM (Figure). In mice, the abundance 
of kidney ARH protein was modulated by dietary potassium 
and inversely correlated with changes in ROMK. Furthermore, 
ARH-knockout mice exhibited an altered ROMK response to 
potassium intake. These data indicate that ARH marks ROMK 
for clathrin-dependent endocytosis, in response to the demands 
of potassium homeostasis.
Juan Oliver
Revascularization versus medical 
therapy for renal artery stenosis
ASTRAL Investigators, N Engl J Med 2009; 361: 1953–1962
Multiple trials have examined the utility of renal artery revas-
cularization in the presence of renal artery stenosis.1–3 Despite 
recurrently neutral results, the practice of renal artery angioplasty 
has increased over the years.4
The Angioplasty and Stent for Renal Artery Lesions (ASTRAL) 
trial was a multicenter, randomized, unblinded clinical trial 
with 806 patients. Eligible patients had substantial anatomical 
stenosis in at least one renal artery suitable for endovascular 
revascularization. Further, their doctors needed to be uncer-
tain of the benefit from revascularization. Patients were ran-
domly assigned to undergo either revascularization and medical 
therapy or medical therapy alone. Randomization was stratified 
on multiple factors indicative of kidney function and severity 
of renal artery stenosis. The primary outcome was the change 
in kidney function assessed by the slope of the reciprocal of 
serum creatinine over time. Almost 60% had severe renal artery 
lesions of more than 70%. The procedure was attempted in 83% 
of patients randomized to the revascularization group, with a 
technical success rate of 95%. Six percent of those randomized 
to the medical therapy group also had to underago revascular-
ization. The overall mean slope of the reciprocal of the serum 
creatinine was –0.07 × 10–3 liters per micromole per year in the 
revascularization group as compared with –0.13 × 10–3 liters per 
micromole in the medical therapy group. This difference favored 
revascularization but was statistically insignificant. A similar 
trend was seen in mean systolic pressure. The revascularization 
group had a 1.6-mm Hg difference in blood pressure, but this 
was not statistically significant as compared with the medical 
group. Finally, no differences in renal end points, cardiovascular 
events, or mortality were seen between groups. However, there 
were significant complications of revascularization. Thirty-eight 
procedural complications were reported in 31 patients, includ-
ing renal artery embolization, renal artery occlusion, renal artery 
perforation, and cholesterol embolism.
To understand how this trial relates to prior studies, we should 
note its exclusion of patients thought to be good candidates for 
revascularization. Therefore, while the study helps us to focus on 
who should not undergo revascularization, further investigation 
will be needed to help us to identify the subgroups that might 
truly benefit from revascularization.
Lynda Szczech
1N Engl J Med 2000; 342: 1007–1014. 2Nephrol Dial Transplant 2003; 18: 298–304. 
3Lancet 1997; 349: 1133–1136. 4Kidney Int advance online publication, 28 October 2009, 
doi:10.1038/ki.2009.406.
Colocalization of ARH and ROMK in the kidney. Immunofluorescent staining 
of ROMK (a), ARH (b), and colocalization (c).
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